图4 ASCO指南专家委员会共同主席Gary H. Lyman, MD, MPH & Lorenzo Cohen, PhD
因此,这一指南的目标读者不仅包括各种临床从业人员,包括临床医师、护士、药师等,乳腺癌患者也被考虑在内。
通过这份指南一定程度上解答了这一系列的问题:什么是囊括了常规和补充疗法在内的综合疗法?哪些补充疗法能在乳腺癌的治疗过程中和治疗后被使用?其中又有哪些补充疗法有循证证据的充分支持?——为乳腺癌患者安全、有效地选择补充疗法,避免无谓的花销,提供了指导。
[1] Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortettieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. Ca A Cancer Journal for Clinicians, 65(2), 87-108. doi: 10.3322/caac.21262.
[4] F. Paulson & J. Waschke. (2011). Sobotta Atlas of Anatomy Latin Nomenclature, General Anatomy and Musculoskeletal System, 15th Edition. URBAN & FISCHER, Miinchen. pp.115, Fig 2.136; pp.117, Fig 2.141.
[5] Greenlee H, Balneaves LG, Carlson LE, et al. (2014). Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr. 2014 Nov;2014(50):346-58. doi: 10.1093/jncimonographs/lgu041.
[6] Greenlee H ,DuPont-Reyes MJ, Balneaves LG, et al. (2017). Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During and After Breast Cancer Treatment. CA Cancer J Clin. 2017 May 6;67(3):194-232. doi: 10.3322/caac.21397.
[7] Lyman GH, Greenlee H, Bohlke K, et al. (2018). Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol. 2018 Jun 11:JCO2018792721. doi: 10.1200/JCO.2018.79.2721.
[8] Judge DE. Integrating Complementary Therapies with Conventional Breast Cancer Treatment. NEJM Journal Watch. June 27, 2018. Available at: https://www.jwatch.org/na46986/2018/06/27/integrating-complementary-therapies-with-conventional Last assessed on 2018-08-05.